Literature DB >> 30614814

Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome.

Elena Gallo MacFarlane1,2, Sarah J Parker1,3, Joseph Y Shin4, Benjamin E Kang1, Shira G Ziegler4, Tyler J Creamer2,4, Rustam Bagirzadeh1,2, Djahida Bedja3, Yichun Chen1, Juan F Calderon4, Katherine Weissler5, Pamela A Frischmeyer-Guerrerio5, Mark E Lindsay1,6, Jennifer P Habashi1,6, Harry C Dietz1,7.   

Abstract

The aortic root is the predominant site for development of aneurysm caused by heterozygous loss-of-function mutations in positive effectors of the transforming growth factor-β (TGF-β) pathway. Using a mouse model of Loeys-Dietz syndrome (LDS) that carries a heterozygous kinase-inactivating mutation in TGF-β receptor I, we found that the effects of this mutation depend on the lineage of origin of vascular smooth muscle cells (VSMCs). Secondary heart field-derived (SHF-derived), but not neighboring cardiac neural crest-derived (CNC-derived), VSMCs showed impaired Smad2/3 activation in response to TGF-β, increased expression of angiotensin II (AngII) type 1 receptor (Agtr1a), enhanced responsiveness to AngII, and higher expression of TGF-β ligands. The preserved TGF-β signaling potential in CNC-derived VSMCs associated, in vivo, with increased Smad2/3 phosphorylation. CNC-, but not SHF-specific, deletion of Smad2 preserved aortic wall architecture and reduced aortic dilation in this mouse model of LDS. Taken together, these data suggest that aortic root aneurysm predisposition in this LDS mouse model depends both on defective Smad signaling in SHF-derived VSMCs and excessive Smad signaling in CNC-derived VSMCs. This work highlights the importance of considering the regional microenvironment and specifically lineage-dependent variation in the vulnerability to mutations in the development and testing of pathogenic models for aortic aneurysm.

Entities:  

Keywords:  Monogenic diseases; Mouse models; Signal transduction; Vascular Biology

Mesh:

Substances:

Year:  2019        PMID: 30614814      PMCID: PMC6355234          DOI: 10.1172/JCI123547

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  89 in total

Review 1.  Medical therapy of thoracic aortic aneurysms: are we there yet?

Authors:  Peter Danyi; John A Elefteriades; Ion S Jovin
Journal:  Circulation       Date:  2011-09-27       Impact factor: 29.690

Review 2.  Extracellular regulation of transforming growth factor beta and bone morphogenetic protein signaling in bone.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Gabriella Siciliano; Silvia Smaldone; Francesco Ramirez
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

3.  Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.

Authors:  Mark E Lindsay; Dorien Schepers; Nikhita Ajit Bolar; Jefferson J Doyle; Elena Gallo; Justyna Fert-Bober; Marlies J E Kempers; Elliot K Fishman; Yichun Chen; Loretha Myers; Djahita Bjeda; Gretchen Oswald; Abdallah F Elias; Howard P Levy; Britt-Marie Anderlid; Margaret H Yang; Ernie M H F Bongers; Janneke Timmermans; Alan C Braverman; Natalie Canham; Geert R Mortier; Han G Brunner; Peter H Byers; Jennifer Van Eyk; Lut Van Laer; Harry C Dietz; Bart L Loeys
Journal:  Nat Genet       Date:  2012-07-08       Impact factor: 38.330

Review 4.  Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility.

Authors:  Erine H Budi; Dana Duan; Rik Derynck
Journal:  Trends Cell Biol       Date:  2017-05-25       Impact factor: 20.808

5.  Late complications and distal growth rates of Marfan aortas after proximal aortic repair.

Authors:  Fabian A Kari; Maximilian F Russe; Prisca Peter; Philipp Blanke; Bartosz Rylski; Wulf Euringer; Friedhelm Beyersdorf; Matthias Siepe
Journal:  Eur J Cardiothorac Surg       Date:  2013-01-07       Impact factor: 4.191

6.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

7.  GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.

Authors:  Ping Ye; Wenhao Chen; Jie Wu; Xiaofan Huang; Jun Li; Sihua Wang; Zheng Liu; Guohua Wang; Xiao Yang; Peng Zhang; Qiulun Lv; Jiahong Xia
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

Review 8.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

9.  Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.

Authors:  Jennifer P Habashi; Jefferson J Doyle; Tammy M Holm; Hamza Aziz; Florian Schoenhoff; Djahida Bedja; YiChun Chen; Alexandra N Modiri; Daniel P Judge; Harry C Dietz
Journal:  Science       Date:  2011-04-15       Impact factor: 47.728

10.  Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation.

Authors:  Franco Klingberg; Melissa L Chow; Anne Koehler; Stellar Boo; Lara Buscemi; Thomas M Quinn; Mercedes Costell; Benjamin A Alman; Elisabeth Genot; Boris Hinz
Journal:  J Cell Biol       Date:  2014-10-20       Impact factor: 10.539

View more
  34 in total

1.  Chronic mTOR activation induces a degradative smooth muscle cell phenotype.

Authors:  Guangxin Li; Mo Wang; Alexander W Caulk; Nicholas A Cilfone; Sharvari Gujja; Lingfeng Qin; Pei-Yu Chen; Zehua Chen; Sameh Yousef; Yang Jiao; Changshun He; Bo Jiang; Arina Korneva; Matthew R Bersi; Guilin Wang; Xinran Liu; Sameet Mehta; Arnar Geirsson; Jeffrey R Gulcher; Thomas W Chittenden; Michael Simons; Jay D Humphrey; George Tellides
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

2.  In Vitro Lineage-Specific Differentiation of Vascular Smooth Muscle Cells in Response to SMAD3 Deficiency: Implications for SMAD3-Related Thoracic Aortic Aneurysm.

Authors:  Jian Gong; Dong Zhou; Longtan Jiang; Ping Qiu; Dianna M Milewicz; Y Eugene Chen; Bo Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-14       Impact factor: 8.311

Review 3.  Genetic evidence for the role of transforming growth factor-β in atopic phenotypes.

Authors:  Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Immunol       Date:  2019-06-01       Impact factor: 7.486

4.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Authors:  Caitlin J Bowen; Juan Francisco Calderón Giadrosic; Zachary Burger; Graham Rykiel; Elaine C Davis; Mark R Helmers; Kelly Benke; Elena Gallo MacFarlane; Harry C Dietz
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

5.  Generation of Embryonic Origin-Specific Vascular Smooth Muscle Cells from Human Induced Pluripotent Stem Cells.

Authors:  Mengcheng Shen; Chun Liu; Joseph C Wu
Journal:  Methods Mol Biol       Date:  2022

6.  Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies.

Authors:  Hisashi Sawada; Yuriko Katsumata; Hideyuki Higashi; Chen Zhang; Yanming Li; Stephanie Morgan; Lang H Lee; Sasha A Singh; Jeff Z Chen; Michael K Franklin; Jessica J Moorleghen; Deborah A Howatt; Debra L Rateri; Ying H Shen; Scott A LeMaire; Masanori Aikawa; Mark W Majesky; Hong S Lu; Alan Daugherty
Journal:  Circulation       Date:  2022-02-10       Impact factor: 29.690

7.  Embryologic Origin Influences Smooth Muscle Cell Phenotypic Modulation Signatures in Murine Marfan Syndrome Aortic Aneurysm.

Authors:  Albert J Pedroza; Alex R Dalal; Rohan Shad; Nobu Yokoyama; Ken Nakamura; Paul Cheng; Robert C Wirka; Olivia Mitchel; Michael Baiocchi; William Hiesinger; Thomas Quertermous; Michael P Fischbein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-07       Impact factor: 10.514

8.  Inhibition of the Renin-Angiotensin System Fails to Suppress β-Aminopropionitrile-Induced Thoracic Aortopathy in Mice-Brief Report.

Authors:  Hisashi Sawada; Satoko Ohno-Urabe; Dien Ye; Michael K Franklin; Jessica J Moorleghen; Deborah A Howatt; Adam E Mullick; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-08-25       Impact factor: 10.514

9.  Aortic progression and reintervention in patients with pathogenic variants after a thoracic aortic dissection.

Authors:  Elizabeth L Norton; Whitney E Hornsby; Xiaoting Wu; Brooke N Wolford; Sarah E Graham; Cristen J Willer; Bo Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2020-02-20       Impact factor: 5.209

10.  Characterization of the Rate of Aortic Dilation in Young Patients with Thoracic Aortic Aneurysm.

Authors:  Adam P Wheeler; Ziyi Yang; Timothy M Cordes; Larry W Markham; Benjamin J Landis
Journal:  Pediatr Cardiol       Date:  2020-10-01       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.